The data shown below were collected from the profiles of 211 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
|
---|---|
Published in |
The Lancet Diabetes & Endocrinology, July 2024
|
DOI | 10.1016/s2213-8587(24)00155-4 |
Pubmed ID | |
Authors |
Ellen M Apperloo, Brendon L Neuen, Robert A Fletcher, Niels Jongs, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, William G Herrington, Silvio E Inzucchi, Meg J Jardine, Chih-Chin Liu, Kenneth W Mahaffey, Darren K McGuire, John J V McMurray, Bruce Neal, Milton Packer, Vlado Perkovic, Marc S Sabatine, Scott D Solomon, Natalie Staplin, Michael Szarek, Muthiah Vaduganathan, Christoph Wanner, David C Wheeler, Stephen D Wiviott, Faiez Zannad, Hiddo J L Heerspink |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Thailand | 1 | <1% |
United Kingdom | 1 | <1% |
Unknown | 208 | 99% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 151 | 72% |
Scientists | 38 | 18% |
Practitioners (doctors, other healthcare professionals) | 17 | 8% |
Science communicators (journalists, bloggers, editors) | 5 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 20 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 8 | 40% |
Researcher | 3 | 15% |
Student > Doctoral Student | 2 | 10% |
Student > Ph. D. Student | 2 | 10% |
Other | 1 | 5% |
Other | 2 | 10% |
Unknown | 2 | 10% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 8 | 40% |
Medicine and Dentistry | 6 | 30% |
Immunology and Microbiology | 2 | 10% |
Psychology | 1 | 5% |
Unknown | 3 | 15% |
Attention Score in Context
This research output has an Altmetric Attention Score of 343. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2024.
All research outputs
#102,275
of 26,629,686 outputs
Outputs from The Lancet Diabetes & Endocrinology
#109
of 2,251 outputs
Outputs of similar age
#1,295
of 302,592 outputs
Outputs of similar age from The Lancet Diabetes & Endocrinology
#3
of 46 outputs
Altmetric has tracked 26,629,686 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,251 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 78.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 302,592 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.